GlaxoSmithKline (GSK) stock forecast for 2024

The forecast has been updated: November 30, 2022 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

44.92

Dividend Date

12.01.2023

Ex Dividend Date

17.11.2022

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $44.92 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the resistance level (38.92 $).

50 Day Moving Average is the support level (31.57 $).




GSK Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 30.85 30.03 31.11 3.48 %
Mar 30.84 29.96 31.49 4.85 %
Mar 30.98 30.55 31.34 2.54 %
Apr 31.83 31.17 32.07 2.82 %
May 32.34 31.33 33.17 5.55 %
Jun 33.05 32.16 33.48 3.93 %
Jul 31.83 31.48 32.08 1.86 %
Aug 31.07 30.65 31.58 2.95 %
Sep 30.60 29.95 31.01 3.39 %
Oct 30.31 29.76 30.55 2.59 %
Nov 30.49 30.05 30.91 2.77 %
Dec 31.54 30.79 32.14 4.21 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

70 345 335 000 $

EBITDA

11 716 000 000

PE Ratio

13.05

PEG Ratio

1.078

Dividend Per Share

0.762

Dividend Yield

0.0552

EPS

2.65

Quarterly Earnings Growth YOY

7.77

Quarterly Revenue Growth YOY

0.181

Trailing PE

13.05

Forward PE

9.4

EV To Revenue

2.255

EV To EBITDA

8.84

52 Week High

46.48

52 Week Low

28.19

50 Day Moving Average

31.57

200 Day Moving Average

38.92

Shares Outstanding

2033690000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.85. Negative monthly dynamics of the instrument is expected with 3.480% volatility is expected.

Pessimistic forecast: 30.03

Optimistic: 31.11


GlaxoSmithKline stock forecast for Mar 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.84. Negative monthly dynamics of the instrument is expected with 4.851% volatility is expected.

Pessimistic forecast: 29.96

Optimistic: 31.49


GlaxoSmithKline stock forecast for Mar 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.98. Positive monthly dynamics of the instrument is expected with 2.544% volatility is expected.

Pessimistic forecast: 30.55

Optimistic: 31.34


GlaxoSmithKline stock forecast for Apr 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 31.83. Positive monthly dynamics of the instrument is expected with 2.825% volatility is expected.

Pessimistic forecast: 31.17

Optimistic: 32.07


GlaxoSmithKline stock forecast for May 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 32.34. Positive monthly dynamics of the instrument is expected with 5.551% volatility is expected.

Pessimistic forecast: 31.33

Optimistic: 33.17


GlaxoSmithKline stock forecast for Jun 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 33.05. Positive monthly dynamics of the instrument is expected with 3.928% volatility is expected.

Pessimistic forecast: 32.16

Optimistic: 33.48


GlaxoSmithKline stock forecast for Jul 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 31.83. Negative monthly dynamics of the instrument is expected with 1.857% volatility is expected.

Pessimistic forecast: 31.48

Optimistic: 32.08


GlaxoSmithKline stock forecast for Aug 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 31.07. Negative monthly dynamics of the instrument is expected with 2.955% volatility is expected.

Pessimistic forecast: 30.65

Optimistic: 31.58


GlaxoSmithKline stock forecast for Sep 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.60. Negative monthly dynamics of the instrument is expected with 3.387% volatility is expected.

Pessimistic forecast: 29.95

Optimistic: 31.01


GlaxoSmithKline stock forecast for Oct 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.31. Negative monthly dynamics of the instrument is expected with 2.593% volatility is expected.

Pessimistic forecast: 29.76

Optimistic: 30.55


GlaxoSmithKline stock forecast for Nov 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 30.49. Positive monthly dynamics of the instrument is expected with 2.770% volatility is expected.

Pessimistic forecast: 30.05

Optimistic: 30.91


GlaxoSmithKline stock forecast for Dec 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 31.54. Positive monthly dynamics of the instrument is expected with 4.210% volatility is expected.

Pessimistic forecast: 30.79

Optimistic: 32.14



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.07 (04.11.2022) 1.68 %
AbbVie Inc.
ABBV 145.28 (04.11.2022) 0.60 %
Aeterna Zentaris Inc.
AEZS 4.01 (04.11.2022) 2.82 %
Allakos Inc.
ALLK 5.99 (04.11.2022) 5.83 %
Allogene Therapeutics, Inc.
ALLO 9.34 (04.11.2022) -1.89 %
Amgen Inc.
AMGN 269.04 (04.11.2022) 1.19 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.75 (04.11.2022) 2.15 %
Aurora Cannabis Inc.
ACB 1.31 (04.11.2022) -5.07 %
Becton Dickinson and Company
BDX 220.84 (04.11.2022) -0.07 %
Biogen Inc.
BIIB 281.82 (04.11.2022) 0.56 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 15.47 (04.11.2022) 4.60 %
BioNTech SE
BNTX 154.31 (04.11.2022) 6.24 %
bluebird bio, Inc.
BLUE 6.13 (04.11.2022) -2.23 %
Boston Scientific Corp.
BSX 41.59 (04.11.2022) 0.14 %
Bristol-Myers Squibb Company
BMY 78.78 (04.11.2022) 0.38 %
Canopy Growth Corp.
CGC 3.29 (04.11.2022) -4.64 %
Castle Biosciences, Inc.
CSTL 21.94 (04.11.2022) -9.60 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 19.96 (04.11.2022) 2.20 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 8.32 (04.11.2022) 4.92 %
Gilead Sciences, Inc.
GILD 80.34 (04.11.2022) 1.11 %
GlaxoSmithKline plc
GSK 32.99 (04.11.2022) 0.46 %
GoodRx Holdings, Inc.
GDRX 5.06 (04.11.2022) 3.27 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.3 (04.11.2022) 0.52 %
Inovio Pharmaceuticals, Inc.
INO 2.11 (04.11.2022) -1.40 %
Johnson & Johnson
JNJ 171.48 (04.11.2022) 0.45 %
Medtronic plc.
MDT 84.65 (04.11.2022) 0.75 %
Merck & Co., Inc.
MRK 99.2 (04.11.2022) 0.46 %
Moderna, Inc.
MRNA 158.41 (04.11.2022) 7.40 %
Novartis AG
NVS 81.72 (04.11.2022) 1.67 %
Novavax, Inc.
NVAX 19.4 (04.11.2022) -3.82 %
ObsEva SA
OBSV 0.1688 (04.11.2022) 0.60 %
OrganiGram Holdings Inc.
OGI 0.9738 (04.11.2022) 0.11 %
Pfizer Inc.
PFE 47.22 (04.11.2022) 1.40 %
Regeneron Pharmaceuticals, Inc.
REGN 740.21 (04.11.2022) 0.21 %
Sanofi
SNY 43.62 (04.11.2022) 1.82 %
Schrodinger, Inc.
SDGR 20.92 (04.11.2022) -15.17 %
Senseonics Holdings, Inc.
SENS 1.18 (04.11.2022) -0.84 %
Sorrento Therapeutics, Inc.
SRNE 1.46 (04.11.2022) -1.35 %
Stryker Corp.
SYK 210.98 (04.11.2022) 2.66 %
Sundial Growers Inc.
SNDL 2.32 (04.11.2022) -2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.47 (04.11.2022) -1.63 %
Thermo Fisher Scientific Inc.
TMO 495.55 (04.11.2022) 1.77 %
Tilray, Inc.
TLRY 3.81 (04.11.2022) -0.26 %
UnitedHealth Group, Inc.
UNH 538.17 (04.11.2022) -1.00 %
Veeva Systems Inc.
VEEV 166.81 (04.11.2022) -0.20 %
Zomedica Corp.
ZOM 0.2245 (04.11.2022) -2.01 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.7051 (04.11.2022) -2.07 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.